Latest profit margin for Hangzhou Tigermed Consulting , Ltd: -5.27% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2026
Trailing 12 months ending Sep 2026
As of the most recent data (September 2026), 3347.HK shows a profit margin of -5.27%. That compares with 9.29% in the prior-year period — down 156.7% year over year. That is below the Healthcare sector average of 17.63%. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, 3347.HK's profit margin is now -5.27% (was 9.29%) — a 156.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Hangzhou Tigermed Consulting , Ltd is outperforming or lagging.
The Healthcare sector average profit margin is about 17.63%. Hangzhou Tigermed Consulting , Ltd is at -5.27%, which is lower that average. That is roughly 129.9% below the sector mean. Use the comparison chart on this page to see how 3347.HK stacks up against individual peers as well.
That compares with 9.29% in the prior-year period — down 156.7% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Hangzhou Tigermed Consulting , Ltd with peers to see if the move is company-specific or sector-wide.
Besides this profit margin page, Stockcircle has Hangzhou Tigermed Consulting , Ltd's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -5.27%) with ownership activity and broader fundamentals.